Zagreb, Croatia

Nedjeljko Kujundzic

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1998-2008

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Nedjeljko Kujundzic: Innovator in Macrolide Antibiotics

Introduction

Nedjeljko Kujundzic is a prominent inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel macrolide antibiotics. With a total of five patents to his name, Kujundzic's work has had a substantial impact on medical science.

Latest Patents

Kujundzic's latest patents include innovative compounds such as substituted 9a-N-(N'-(sulfonyl)phenylcarbamoyl) derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithomycin A and 5-0-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerithronolide A. These inventions relate to novel semisynthetic macrolide antibiotics of the azalide series, which are designed for use in pharmaceutical compositions and for sterilization purposes. Another significant patent involves N''-substituted derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithromycin A, which are also aimed at treating bacterial infections.

Career Highlights

Throughout his career, Kujundzic has worked with several notable companies, including Pliva, Farmaceutska, Kemijska, and Prehrambena i Kozmetička Industrija. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Kujundzic has collaborated with several professionals in his field, including Mirjana Bukvic Krajacic and Dina Pavlovic. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Nedjeljko Kujundzic is a distinguished inventor whose work in macrolide antibiotics has made a significant impact on the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science and improving treatment options for bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…